Fennec Pharmaceuticals (FENC) Other Operating Expenses (2016 - 2026)

Fennec Pharmaceuticals (FENC) has 5 years of Other Operating Expenses data on file, last reported at -$10.5 million in Q4 2025.

• Quarterly Other Operating Expenses fell 1559.81% year-over-year to -$10.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.0 million (down 146.21% YoY) and the FY2025 annual result came in at $4.0 million, up 14.98% from the prior year.
• Other Operating Expenses retreated to -$10.5 million in Q4 2025, from $689000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $5.8 million in Q1 2024 to a low of -$10.5 million in Q4 2025.
• A 4-year average of $532500.0 and a median of $1.1 million in 2024 frame the typical range for Other Operating Expenses.
• The widest YoY moves for Other Operating Expenses: up 595.56% in 2025, down 1559.81% in 2025.
• Tracing FENC's Other Operating Expenses over 4 years: stood at $2.8 million in 2022, then soared by 63.48% to $4.6 million in 2023, then slumped by 84.21% to $719000.0 in 2024, then slumped by 1559.81% to -$10.5 million in 2025.
• The last three Other Operating Expenses figures came in at -$10.5 million (Q4 2025), $689000.0 (Q3 2025), and $5.3 million (Q2 2025), per Business Quant data.